SNCA and Parkinson disease: Due to the implications of GBA-associated lysosomal dysfunction and PD-associated pathologies, GluCer synthesis and metabolism have become promising targets for therapeutic intervention [254, 263–265], as have molecules such as ubiquitin ligase NEDD4, which target alpha-synuclein for lysosomal destruction [266].